Nomura Research Institute (NRILY)
(Delayed Data from OTC)
$34.76 USD
+0.18 (0.52%)
Updated Oct 4, 2024 03:59 PM ET
1-Strong Buy of 5 1
D Value B Growth A Momentum C VGM
Income Statements
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 5,082 | 5,122 | 5,444 | 4,971 | 4,861 |
Cost Of Goods | 3,281 | 3,347 | 3,521 | 3,293 | 3,198 |
Gross Profit | 1,801 | 1,775 | 1,923 | 1,678 | 1,662 |
Selling & Adminstrative & Depr. & Amort Expenses | 982 | 974 | 1,010 | 889 | 898 |
Income After Depreciation & Amortization | 819 | 801 | 913 | 790 | 764 |
Non-Operating Income | 36 | 43 | 50 | -44 | 181 |
Interest Expense | 46 | 41 | 31 | 104 | 4 |
Pretax Income | 809 | 803 | 932 | 642 | 942 |
Income Taxes | 256 | 237 | 293 | 167 | 297 |
Minority Interest | 4 | 1 | 3 | -3 | 9 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 553 | 566 | 639 | 475 | 645 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 550 | 565 | 636 | 478 | 637 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,151 | 1,135 | 1,286 | 1,159 | 1,044 |
Depreciation & Amortization (Cash Flow) | 332 | 334 | 373 | 370 | 280 |
Income After Depreciation & Amortization | 819 | 801 | 913 | 790 | 764 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 582.02 | 591.89 | 593.69 | 598.44 | 635.15 |
Diluted EPS Before Non-Recurring Items | 0.95 | 0.95 | 1.07 | 1.07 | 1.00 |
Diluted Net EPS (GAAP) | 0.90 | 0.95 | 1.07 | 0.80 | 4.11 |
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 1,206.67 | 1,256.14 | 1,272.82 | 1,282.85 | 1,289.98 |
Cost Of Goods | NA | NA | NA | NA | 828.83 |
Gross Profit | NA | NA | NA | NA | 461.15 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 258.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 203.15 |
Non-Operating Income | NA | NA | NA | NA | 1.68 |
Interest Expense | NA | NA | NA | NA | 10.80 |
Pretax Income | NA | NA | NA | NA | 194.03 |
Income Taxes | NA | NA | NA | NA | 67.79 |
Minority Interest | NA | NA | NA | NA | 0.61 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | 142.19 | 124.92 | 158.68 | 141.55 | 126.25 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 142.19 | 124.92 | 158.68 | 141.55 | 125.64 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 575.59 | 575.73 | 578.12 | 584.68 | 590.40 |
Diluted EPS Before Non-Recurring Items | 0.25 | 0.22 | 0.27 | 0.24 | 0.21 |
Diluted Net EPS (GAAP) | 0.25 | 0.22 | 0.27 | 0.24 | 0.21 |